About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Serum Clozapine and Cognition | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00951418

Serum Clozapine and Cognition

This study aim to investigate the relationship between serum levels of clozapine and cognitive performance in patients with ICD-10 Schizophrenia and treated with clozapine monotherapy. The hypothesis ...

Lead sponsor: University of Aarhus•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Aarhus

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Treated with clozapine for minimum 6 months.
•Fixed dosage of clozapine last month before inclusion.

Exclusion Criteria

•Substance misuse.
•Depression (Calgary Depression score ≥7).
•Somatic disease that interfere with cognitive performance.
•Treatment with benzodiazepines (half-lives \>15 hours not allowed up 14 days prior inclusion and during study. Half-lives \< 15 hours not allowed 3 days prior cognitive testing).
•Electroconvulsive therapy.
•Treatment with other antipsychotics.
•Withdrawal of informed consent.
•Compulsory measures.
•Treatment with anticholinergics except for atropine drops administered sublingually.
•Changes in use of tobacco last month before inclusion.

Related studies

RECRUITINGPhase 3

Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic Medications

NCT07565428 · Negative Symptoms of Schizophrenia

FEEL-GOOD: A Multicenter Trial of a Mindfulness-Based Group Therapy in Young Adults With Early Psychosis

NCT07645443 · Early Onset Psychosis, First Psychotic Episode Within the Last 5 Years, and more

Deep Brain Stimulation for Psychosis

NCT06257056 · Treatment-Refractory Schizophrenia

RECRUITINGPhase 2

Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia

NCT07288333 · Schizophrenia

RECRUITINGPhase 3

NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

NCT07105098 · Schizophrenia

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 12, 2013Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment10

Start dateJun 2009

Last updatedSep 12, 2013

Condition

Locations shown

Aalborg Psychiatric Hospital

Aalborg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 12, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions